Home › All Companies › CLPT › Annual Report

ClearPoint Neuro, Inc. (CLPT) — Annual Report

AI-Powered SEC Filing Analysis

← All CLPT filings
Latest Annual Report Filed: 2026-03-17

Key Insights

  • ClearPoint Neuro has seen consistent growth in its Neurosurgery Navigation and Therapy segment, which generated $X million in revenue in 2025, up Y% from the prior year.
  • The company is expanding its product portfolio with the launch of new Capital Equipment and Software Systems and Software Products, which contributed $Z million in revenue in 2025.
  • ClearPoint Neuro has secured a $X million financing agreement with TPC Investments III LP, which will provide additional capital to support the company's growth initiatives.
Sentiment: Positive Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-03-17. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for ClearPoint Neuro, Inc.

Insider Trading Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.